Cargando…
Drug Resistance in Glioblastoma: The Two Faces of Oxidative Stress
Glioblastomas (GBM) are the most common primary brain tumor with a median survival of 15 months. A population of cells with stem cell properties (glioblastoma stem cells, GSCs) drives the initiation and progression of GBM and is localized in specialized microenvironments which support their behavior...
Autores principales: | Olivier, Christophe, Oliver, Lisa, Lalier, Lisenn, Vallette, François M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873048/ https://www.ncbi.nlm.nih.gov/pubmed/33585565 http://dx.doi.org/10.3389/fmolb.2020.620677 |
Ejemplares similares
-
Drug resistance in glioblastoma: are persisters the key to therapy?
por: Oliver, Lisa, et al.
Publicado: (2020) -
Bcl-2 Family Members and the Mitochondrial Import Machineries: The Roads to Death
por: Lalier, Lisenn, et al.
Publicado: (2022) -
Increase in intracellular PGE(2 )induces apoptosis in Bax-expressing colon cancer cell
por: Lalier, Lisenn, et al.
Publicado: (2011) -
Targeting Metabolism to Induce Cell Death in Cancer Cells and Cancer Stem Cells
por: Pecqueur, Claire, et al.
Publicado: (2013) -
Radiation-induced PGE(2) sustains human glioma cell growth and survival through EGF signaling
por: Brocard, Emeline, et al.
Publicado: (2015)